Hong Kong Stock Market Exceptionally Active | Welling Pharmaceuticals -B (02552.HK) Surges Over 4% in the Afternoon, Company's Second Generation GKA has Submitted Clinical Application to FDA, Industry Research and Development in Leading Position

According to the Wisdom Finance and Economics app, Hualing Pharmaceutical-B (02552.HK) rose more than 4% in the final trading session, with an increase of 3.55% as of the time of this report, closing at 3.5 Hong Kong dollars with a turnover of 16.7041 million Hong Kong dollars.